GLICLAZIDE VIATRIS 60 mg, scored tablet with modified release 30 tablets, CIP 3400930136577
Active ingredients: Gliclazide
Commercialized according to BDPMDispensing in France: Prescription only
Modified-release tablet scored30 tablets, CIP 3400930136577orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLICLAZIDE VIATRIS 60 mg, comprimé sécable à libération modifiée
- Pharmaceutical form
- comprimé à libération modifiée sécable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Jan 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65064520CIP73013657CIP133400930136577Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GLICLAZIDEcomprimé | 60 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.